2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hypochlorous Acid Can Be the Novel Option for the Meibomian Gland Dysfunction Dry Eye through Ultrasonic Atomization

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Dry eye is a multifactor disease which needs comprehensive treatments to keep the homeostasis of ocular surface.

          Objective

          To explore the effect of hypochlorous acid on the meibomian gland dysfunction dry eye through ultrasonic atomization.

          Methods

          We set this study of 0.01% HOCL and 0.1% hyaluronate by ultrasonic atomization. All the data was recorded at the 1 st, 15 th, 30 th, and 55 th days. The patients' complains, the meibum analysis, conjunctive congestion, corneal staining, Schirmer's I test, and NIBUT were recorded by K5M, the MMP-9, and IL-2 of tear by inflammation kit; the Demodex was recorded by microscopy.

          Results

          53 patients have joined this study. There is no statistic difference between them on OSDI (day 15: p = 0.061, 30: p = 0.055, 55: p = 0.052); results show the 10.57 ± 0.13 and 12.54 ± 0.17 reduction on OSDI; the differences of both treatments are significant ( ∗∗ p < 0.01). Increased Schirmer's and TBUT are 3.27 ± 0.10 and 6.29 ± 0.10 ( ∗∗ p < 0.01) or 7.32 ± 1.72 s and 9.22 ± 1.41 s ( p < 0.05); the decreased conjunctive and corneal staining are 0.23 ± 0.07 and 0.45 ± 0.06 ( ∗∗ p < 0.01) or 0.42 ± 0.03 and 0.37 ± 0.02 ( p < 0.05) at both groups. The differences of MMP-9 and IL-2 negative rate are significant ( Z = 0.896, ∗∗ p = 0.002 < 0.01; Z = 0.659, ∗∗ p = 0.001 < 0.01); the number of Demodex mites at first is 10 or 11, while the last is 2 or 6 ( Z = −4.642, ∗∗ p < 0.01; Z = 2.742, p > 0.05). The Demodex count between them is significant ( Z = −2.310, p = 0.032 < 0.05). The survival times (ST) of each stage at the HOCL are 110.75 (108.50 ± 24.50), 95.50 (90.25 ± 14.50), and 75.25 (73.48 ± 8.50) min which are shorter than those of control which are 155.50 (160.10 ± 21.50), 130.25 (128.25 ± 16.50), and 105.75 (102.50 ± 14.50) min ( ∗∗ p < 0.01). The Demodex eradication rate of HOCL is statistic significant ( p15 th vs. 1 stday = 0.028 < 0.05; ∗∗ p30 th vs. 1 stday = 0.002 < 0.01; ∗∗ p55 th vs. 1 stday = 0.0018 < 0.01).

          Conclusions

          0.01% HOCL improves the Demodex eradication by shortening the survival time; the HOCL acts on the ocular surface by reducing the inflammation. The ultrasonic atomization helps for the drug usage.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

          G*Power (Erdfelder, Faul, & Buchner, 1996) was designed as a general stand-alone power analysis program for statistical tests commonly used in social and behavioral research. G*Power 3 is a major extension of, and improvement over, the previous versions. It runs on widely used computer platforms (i.e., Windows XP, Windows Vista, and Mac OS X 10.4) and covers many different statistical tests of the t, F, and chi2 test families. In addition, it includes power analyses for z tests and some exact tests. G*Power 3 provides improved effect size calculators and graphic options, supports both distribution-based and design-based input modes, and offers all types of power analyses in which users might be interested. Like its predecessors, G*Power 3 is free.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            TFOS DEWS II Epidemiology Report

            The subcommittee reviewed the prevalence, incidence, risk factors, natural history, morbidity and questionnaires reported in epidemiological studies of dry eye disease (DED). A meta-analysis of published prevalence data estimated the impact of age and sex. Global mapping of prevalence was undertaken. The prevalence of DED ranged from 5 to 50%. The prevalence of signs was higher and more variable than symptoms. There were limited prevalence studies in youth and in populations south of the equator. The meta-analysis confirmed that prevalence increases with age, however signs showed a greater increase per decade than symptoms. Women have a higher prevalence of DED than men, although differences become significant only with age. Risk factors were categorized as modifiable/non-modifiable, and as consistent, probable or inconclusive. Asian ethnicity was a mostly consistent risk factor. The economic burden and impact of DED on vision, quality of life, work productivity, psychological and physical impact of pain, are considerable, particularly costs due to reduced work productivity. Questionnaires used to evaluate DED vary in their utility. Future research should establish the prevalence of disease of varying severity, the incidence in different populations and potential risk factors such as youth and digital device usage. Geospatial mapping might elucidate the impact of climate, environment and socioeconomic factors. Given the limited study of the natural history of treated and untreated DED, this remains an important area for future research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reliability and validity of the Ocular Surface Disease Index.

              To evaluate the validity and reliability of the Ocular Surface Disease Index (OSDI) questionnaire. Participants (109 patients with dry eye and 30 normal controls) completed the OSDI, the National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25), the McMonnies Dry Eye Questionnaire, the Short Form-12 (SF-12) Health Status Questionnaire, and an ophthalmic examination including Schirmer tests, tear breakup time, and fluorescein and lissamine green staining. Factor analysis identified 3 subscales of the OSDI: vision-related function, ocular symptoms, and environmental triggers. Reliability (measured by Cronbach alpha) ranged from good to excellent for the overall instrument and each subscale, and test-retest reliability was good to excellent. The OSDI was valid, effectively discriminating between normal, mild to moderate, and severe dry eye disease as defined by both physician's assessment and a composite disease severity score. The OSDI also correlated significantly with the McMonnies questionnaire, the National Eye Institute Visual Functioning Questionnaire, the physical component summary score of the Short Form-12, patient perception of symptoms, and artificial tear usage. The OSDI is a valid and reliable instrument for measuring the severity of dry eye disease, and it possesses the necessary psychometric properties to be used as an end point in clinical trials.
                Bookmark

                Author and article information

                Contributors
                Journal
                Dis Markers
                Dis Markers
                DM
                Disease Markers
                Hindawi
                0278-0240
                1875-8630
                2022
                5 January 2022
                : 2022
                : 8631038
                Affiliations
                1The Diagnosis and Treatment Technology Research and Development Centre for Dry Eye and Ocular Surface Disease of Chenzhou, Chenzhou, 423000 Hunan, China
                2The Ophthalmology Department of the Affiliated Chenzhou Hospital, Hengyan Medical School, University of South China, Chenzhou, 423000 Hunan, China
                3The Operation Department of the Affiliated Chenzhou Hospital, Hengyan Medical School, University of South China, Chenzhou, 423000 Hunan, China
                Author notes

                Academic Editor: Ting Su

                Author information
                https://orcid.org/0000-0003-1719-5337
                Article
                10.1155/2022/8631038
                8754612
                35035613
                4e62e878-7e76-4ab2-8eb3-badc1ce121a4
                Copyright © 2022 Zhiyuan Li et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 22 October 2021
                : 11 December 2021
                : 17 December 2021
                Funding
                Funded by: First People's Hospital of Chenzhou City
                Award ID: N2019-006
                Funded by: University of South China
                Award ID: 2019YJGL04
                Funded by: Chenzhou Science and Technology Bureau
                Award ID: ZDYF-20200092
                Categories
                Research Article

                Comments

                Comment on this article